戻る
Biostem Technologies Inc (BSEM)価格
BSEM 株価推移チャート
BSEM 収入
Biostem Technologies Inc
$6.24
-7.14%
$-0.47
終値： Feb 06, 16:00:00 GMT-5
$6.24
0%
$0
アフターマーケット：Feb 06, 20:00:00 GMT-5
最新の利益結果: Q3 '25
報告済み: 2025-11-13
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
BSEMの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Biostem Technologies Inc BSEMの前四半期の収益はどうでしたか？
Biostem Technologies Incの収益見積もりはいくらですか？
Biostem Technologies Incの収益品質スコアはどれくらいですか？
Biostem Technologies Incはいつ収益を報告しますか？
Biostem Technologies Incの予想収益はいくらですか？
Biostem Technologies Incは収益予想を上回りましたか？
主要データ
前終値
$6.72
始値
$6.85
当日レンジ
$6.16 - $6.85
52週レンジ
$3.09 - $18.6
取引高
93.1K
平均取引高
111.7K
1株当たり利益(TTM)
1.19
配当利回り
--
時価総額
$104.7M
BSEMとは何ですか？
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2001-07-11. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap2 is a placental-based allograft comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.